Prevention of shoulder tip pain after right hemihepatectomy

ISRCTN ISRCTN41856115
DOI https://doi.org/10.1186/ISRCTN41856115
Secondary identifying numbers N0025128440
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
05/12/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr M Hawkins
Scientific

Anaesthesia
University Hospital Aintree
Longmoor Lane
Fazakerley
Liverpool
L9 7AL
United Kingdom

Phone +44 (0)151 529 5152
Email abc@email.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titlePrevention of shoulder tip pain after right hemihepatectomy
Study objectivesTo assess whether infiltration of the diaphragm with local anaesthetic will prevent shoulder tip pain after hemihepatectomy
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSigns and Symptoms: Post-operative pain
InterventionAt end of proposed surgery prior to closure of abdomen, the diaphragm will be infiltrated with 20 ml of solution consisting of either 0.25% bupivicaine or 0.9% saline by the surgeon. Solutions will be made up in Pharmacy and delivered in sterile syringes such that neither surgeon nor anaesthetist will know what has been administered. Closure of abdomen and recovery from anaesthesia will proceed in normal way and patient will be moved to recovery area. When recovered they will be assessed for presence/absence of shoulder-tip and/or abdominal pain. (If abdominal pain is present, epidural will be topped up in usual manner). If shoulder-tip pain is present attempts will be made to rate this as mild, moderate or severe. Rescue analgesia will be with ketorolac as is current practice.
Intervention typeProcedure/Surgery
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/10/2003
Completion date01/02/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants40
Key inclusion criteria40 adult patients
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/10/2003
Date of final enrolment01/02/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University Hospital Aintree
Liverpool
L9 7AL
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Aintree Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan